adenosine diphosphate has been researched along with Grippe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfaro, E; Cubillos-Zapata, C; Díaz-García, E; Galera, R; García-Rio, F; García-Tovar, S; López-Collazo, E; Mangas, A; Nanwani-Nanwani, K; Pérez-de-Diego, R; Rodríguez-Gallego, C; Ruíz-Hernández, JJ; Solé-Violán, J; Van-Den-Rym, A; Zamarrón, E | 1 |
| Atkins, C; Evans, CW; Noah, JW; Nordin, B; Patricelli, MP; Reynolds, R; Wennerberg, K | 1 |
2 other study(ies) available for adenosine diphosphate and Grippe
| Article | Year |
|---|---|
Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Apyrase; Biomarkers; Blood Platelets; Cell Hypoxia; COVID-19; Critical Care; Female; Humans; Influenza A virus; Influenza, Human; Length of Stay; Male; Middle Aged; Platelet Activation; Prognosis; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; SARS-CoV-2; Severity of Illness Index; Signal Transduction; Thromboinflammation; Ticagrelor | 2022 |
Global Human-Kinase Screening Identifies Therapeutic Host Targets against Influenza.
Topics: A549 Cells; Adenosine Diphosphate; Adenosine Triphosphate; Apoptosis; Biotin; Cell Survival; Chromatography, Liquid; Drug Discovery; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mass Spectrometry; NIMA-Related Kinase 1; Peptides; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Serine-Threonine Kinase 3; Viral Load; Virus Replication | 2014 |